Randall Kaye - 08 Feb 2024 Form 4 Insider Report for Longboard Pharmaceuticals, Inc.

Role
CMO
Signature
/s/ Andrew J. Cronauer, Attorney-In-Fact
Issuer symbol
N/A
Transactions as of
08 Feb 2024
Net transactions value
$0
Form type
4
Filing time
09 Feb 2024, 16:11:32 UTC
Previous filing
13 Aug 2024
Next filing
16 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LBPH Common Stock Award $0 +17,920 $0.000000 17,920 08 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LBPH Stock Option (Right to Buy) Award $0 +107,560 $0.000000 107,560 08 Feb 2024 Voting common stock 107,560 $19.32 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount represents restricted stock units that vest in four equal annual installments commencing on February 8, 2025. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.
F2 The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 8, 2024.